Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway

Published:2013 Issue:1 Volume:12 Page:144
ISSN:1476-4598
Container-title:Molecular Cancer
language:en
Short-container-title:Molecular Cancer

Author:

Oliveira-Ferrer Leticia,Wellbrock Jasmin,Bartsch Udo,Murga Penas Eva Maria,Hauschild Jessica,Klokow Marianne,Bokemeyer Carsten,Fiedler Walter,Schuch Gunter

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of IL-17 in the pathogenesis and treatment of glioblastoma—an update on the state of the art and future perspectives;Medical Oncology;2024-06-25

2. The emerging role of mechanical and topographical factors in the development and treatment of nervous system disorders: dark and light sides of the force;Pharmacological Reports;2021-08-14

3. The role of the prolactin receptor pathway in the pathogenesis of glioblastoma: what do we know so far?;Expert Opinion on Therapeutic Targets;2020-09-29

4. Prolactin and its receptor as therapeutic targets in glioblastoma multiforme;Scientific Reports;2019-12

5. An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation;PLOS ONE;2019-05-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP